Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development and validation of real-time recombinase polymerase amplification-based assays for detecting HPV16 and HPV18 DNA

3 Oct 2023

Abstract excerpt

ABSTRACT Cervical cancer is the fourth leading cause of cancer-related death among women worldwide. Persistent human papillomavirus (HPV) infection is the principal cause of cervical cancer, with HPV16 and HPV18 accounting for about 70% of cases worldwide. Cervical screening is an effective secondary measure for preventing cervical cancer. Testing for HPV DNA is becoming increasingly important in cervical cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cervical Cancer and HPV Research
Share to Molecular Biology Techniques and Applications
Share to Vector-Borne Animal Diseases

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37787547
DOI: 10.1128/spectrum.01207-23

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development and validation of real-time recombinase polymerase amplification-based assays for detecting HPV16 and HPV18 DNAPMID 37787547Read ↗

Development of Enzymatic Recombinase Amplification Assays for the Rapid Visual Detection of HPV16/18Semantic proximity Read ↗

Isothermal Method of a Recombinase Polymerase Amplification Assay for the Detection of Most Common High-Risk Human Papillomavirus Type 16 and Type 18 DNA.Semantic proximity Read ↗

Rapid detection of HPV16 utilizing recombinase polymerase amplification with the employment of an extremely low concentration of the probeSemantic proximity Read ↗

Point-of-Care Molecular Test for the Detection of 14 High-Risk Genotypes of Human Papillomavirus in a Single Tube.Semantic proximity Read ↗

Detection of high-risk HPV 16 genotypes in cervical cancers using isothermal DNA amplification with electrochemical genosensor.Semantic proximity Read ↗

Clinical validation of a novel real-time human papillomavirus assay for simultaneous detection of 14 high-risk HPV type and genotyping HPV type 16 and 18 in China.Semantic proximity Read ↗

Concanavalin A-assisted extraction-free one-pot RPA-CRISPR/Cas12a assay for rapid detection of HPV16Semantic proximity Read ↗

Development of a CRISPR/dCas9-based membrane-assisted colorimetric assay for detection of high-risk HPV16 and HPV18: a proof-of-concept study.Semantic proximity Read ↗

A novel multiplex RPA/CRISPR-Cas12a integrated biosensor for on-site detection of high-risk HPV genotypes.Semantic proximity Read ↗

High-throughput detection, genotyping and quantification of the human papillomavirus using real-time PCRSemantic proximity Read ↗

Development and validation of a multiplex qPCR method for identification of high-risk genotypes of human papillomavirusSemantic proximity Read ↗

A Cas12a-based fluorescent microfluidic system for rapid on-site human papillomavirus diagnostics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.